266 related articles for article (PubMed ID: 10189463)
21. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
22. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
Golfieri R; Cherryman GR; Olliff JF; Husband JE
Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
[TBL] [Abstract][Full Text] [Related]
23. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
Balekian AA; Fisher JM; Gould MK
Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
[TBL] [Abstract][Full Text] [Related]
24. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.
Eustace S; Tello R; DeCarvalho V; Carey J; Wroblicka JT; Melhem ER; Yucel EK
AJR Am J Roentgenol; 1997 Dec; 169(6):1655-61. PubMed ID: 9393186
[TBL] [Abstract][Full Text] [Related]
25. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
26. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI.
Yokoi K; Kamiya N; Matsuguma H; Machida S; Hirose T; Mori K; Tominaga K
Chest; 1999 Mar; 115(3):714-9. PubMed ID: 10084481
[TBL] [Abstract][Full Text] [Related]
27. The clinical evaluation for detecting metastatic lung cancer. A meta-analysis.
Silvestri GA; Littenberg B; Colice GL
Am J Respir Crit Care Med; 1995 Jul; 152(1):225-30. PubMed ID: 7599828
[TBL] [Abstract][Full Text] [Related]
28. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
29. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience.
Walker R; Kessar P; Blanchard R; Dimasi M; Harper K; DeCarvalho V; Yucel EK; Patriquin L; Eustace S
J Magn Reson Imaging; 2000 Apr; 11(4):343-50. PubMed ID: 10767062
[TBL] [Abstract][Full Text] [Related]
30. Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis.
Yohena T; Yoshino I; Kitajima M; Uehara T; Kanematsu T; Teruya T; Ikeda J; Ichinose Y
Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):347-9. PubMed ID: 15658906
[TBL] [Abstract][Full Text] [Related]
31. Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates.
Langer C; Hirsh V
Lung Cancer; 2010 Jan; 67(1):4-11. PubMed ID: 19939491
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
[TBL] [Abstract][Full Text] [Related]
33. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
[TBL] [Abstract][Full Text] [Related]
34. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.
Mujoomdar A; Austin JH; Malhotra R; Powell CA; Pearson GD; Shiau MC; Raftopoulos H
Radiology; 2007 Mar; 242(3):882-8. PubMed ID: 17229875
[TBL] [Abstract][Full Text] [Related]
35. Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis.
Jawahar A; Matthew RE; Minagar A; Shukla D; Zhang JH; Willis BK; Ampil F; Nanda A
J Neurosurg; 2004 May; 100(5):842-7. PubMed ID: 15137603
[TBL] [Abstract][Full Text] [Related]
36. Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients.
Marsh JC; Herskovic AM; Gielda BT; Hughes FF; Hoeppner T; Turian J; Abrams RA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):504-12. PubMed ID: 20117288
[TBL] [Abstract][Full Text] [Related]
37. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
[TBL] [Abstract][Full Text] [Related]
38. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced FLAIR imaging in combination with pre- and postcontrast magnetization transfer T1-weighted imaging: usefulness in the evaluation of brain metastases.
Terae S; Yoshida D; Kudo K; Tha KK; Fujino M; Miyasaka K
J Magn Reson Imaging; 2007 Mar; 25(3):479-87. PubMed ID: 17326092
[TBL] [Abstract][Full Text] [Related]
40. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.
Schirrmeister H; Arslandemir C; Glatting G; Mayer-Steinacker R; Bommer M; Dreinhöfer K; Buck A; Hetzel M
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):964-8. PubMed ID: 14991241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
